REN and hydrops fetalis: Renin–angiotensin–aldosterone system (RAAS) inhibitors, such as ACE inhibitors and angiotensin receptor blockers, are cornerstone therapies that provide benefits beyond BP reduction, including mitigating disease progression in both HF and CKD.